Join us on Linkedin   Join us on Facebook

About the New York Section
Membership Info

Section Officers & Committee Chairs

2018 Committee Officer and Member Roster

2018 Officers

Dr. Thomas Franke
Icahn School of Medicine
at Mt. Sinai
1425 Madison Avenue
Mailbox 1065
New York, NY, 10029
Phone: 212-659-1507

Interested in becoming a member of the ACS?
Click here.

American Chemical Society
New York Section, Inc.
Department of Chemistry
St. John's University
8000 Utopia Parkway
Jamaica, NY 11439
Phone 516-883-7510
Fax 516-883-4003

Office Administrator

The Biochemical Topical Group collaborates with the Biochemical Pharmacology Discussion Group (BPDG) of The New York Academy of Sciences (NYAS) to advance our knowledge of the activity and metabolism of small compounds and biologics. The BPDG represents a diverse group of scientists with interests in biochemistry, drug discovery, drug therapy, biomedical research, and related areas. Members are from pharmaceutical and biotechnology companies, and academic institutions. Our purpose is to bring together diverse institutions and communities, industrial and academic researchers, lay-people and experts to share exciting new findings and trends at the frontiers of drug research, development and application.

Each spring, BPDG issues a proposal request for symposia to be held at the NYAS. Topics that will be considered include chemotherapy, neuropharmacology, antimicrobials, inflammation, drug discovery, pharmacology and toxicology. Successful proposals are selected by a Steering Committee and 7-8 receiving the most votes will constitute the next year's program. Selected symposia are held at 7 World Trade Center as half- or full-day events. Lunch, coffee breaks and other networking opportunities at the symposia facilitate interactions and enable conversations.

2018 Meetings

February 20, 2018

Translational Approaches for Human Liver Disease

This symposium will explore emerging in vitro models for non-alcoholic steatohepatitis (NASH) to bridge the gap between existing preclinical animal models and human liver disease.
9:00 AM - 5:00 PM EDT

Non-alcoholic steatohepatitis (NASH) is the second leading cause of disease driving the need for liver transplantation in the United States with no approved treatments currently available. While a number of clinical approaches are under investigation, historically many promising drug candidates have not demonstrated clinical benefit, in part due to an over-reliance on animal models.

In vitro approaches that incorporate primary human cell types to model disease have the potential to improve clinical success by bridging the gap from preclinical animal models to patients. This symposium will present cutting-edge research highlighting current and emerging in vitro model systems, covering potential benefits and limitations for the treatment of liver disease.

Registration Website

March 19, 2018

Cell Death Pathways in Human Health and Disease

This symposium will explore the physiological processes by which cell death contributes to human disease, outlining mechanisms of cell clearance, impact on pathogenesis, and implication for therapeutics.
12:00 PM - 5:00 PM EDT

Cell death is a key driver of human disease. Processes linked to cell death, such as autophagy, further impact immune function, compounding disease pathology. Non-apoptotic cell death modalities (pyroptosis and necroptosis) are currently being investigated as opportunities for therapeutic intervention; however, the molecular pathways and physiological mechanisms controlling the dysfunction are ill-defined. In order to address this important knowledge gap, this symposium will present breaking research mapping the mechanisms by which cell death contributes to homeostasis and human disease, including mechanisms of cell clearance, the impact on pathogenesis and the implication for therapeutics.

Registration Website

April 17, 2018

Advances in Translational Models to Study Fibrosis

This symposium will review what is known about the cell and molecular biology of fibrosis and reparative healing, discuss current model systems, and consider the challenges and opportunities for future innovation.
12:00 PM - 5:00 PM EDT

Fibrosis is a common pathology in many chronic diseases and is often associated with disease progression. Many extracellular matrix macromolecules, as well as their regulators and modifiers have been identified as potential disease targets or biomarkers by extensive studies in numerous preclinical animal models of fibrosis. However, therapeutics development depends on in vitro experimental systems that model pathological processes in order to build assays for screening, mechanistic characterization and target disease link evaluation. In vitro fibrosis experimental systems have been limited, but a better understanding of shared pathways and the distinctions that lead to fibrosis in different organs is now emerging from technical advances such as proteomics, RNAseq, laser capture microdissection and the availability of clinical materials. The advent of engineered substrata with defined biomechanical properties, the use of stem cells and capabilities for genetic modification have also contributed to the design of increasingly sophisticated in vitro models of fibrosis. When coupled with co-culture and organoid technologies, these advances enable modeling of cell and tissue interactions in normal and fibrotic settings. This symposium will review what is known about the cell and molecular biology of fibrosis and reparative healing, discuss current model systems, and consider the challenges and opportunities for future innovation.

Registration Website

May 22, 2018

Thinking Outside the ATP Box: New Ways to Target Kinases for Therapeutics

This symposium will explore new and emerging technologies driving the advancement of drug development pipelines targeting kinase inhibitors.
12:00 PM - 5:00 PM EDT

Over the past few years we have witnessed considerable progress in the field of kinase inhibitors, however there is still no consensus as to which screening methods are best suited to their identification. This symposium will bring together experts in the field of kinase drug discovery to review the landscape, exploring new approaches and technologies driving the advancement of non-classical kinase inhibitor pipeline, and drawing on past lessons to provide insight into the future direction of the field.

Registration Website

September 25, 2018

Neuro-Immunology: The Impact of Immune Function in Alzheimer's Disease

This one-day symposium will build upon genetic evidence for inflammation in Alzheimer's Disease (AD), highlighting cutting-edge science that explores the mechanisms that underlie this intersection between neurology and immunology, and parse the contributions of the immune system to the range of behaviors evidenced over the clinical course of AD.

Registration Website

October 23, 2018

New Therapeutic Strategies to Combat Antibacterial Resistance

This symposium will focus on the current challenges that basic and translational researchers are facing to fight antimicrobial resistance, as well as offering perspectives on emerging therapeutic strategies to address this global health threat.

Registration Website

December 4, 2018

Phagocytes in Health and Disease

This symposium will bring together leaders in the fields of immunology, cancer biology and tissue regeneration to highlight emerging roles for phagocytes in health and disease and develop new conceptual frameworks to integrate macrophage and dendritic cell functions with mammalian development, physiology and tissue biology.

Registration Website

Topical Groups & Committees:
  Chem Mktg/Econ
  Chemists Celebrate Earth Week
  History of the NY Section
         Science History Institute
  National Chemistry Week
  Student Activities
  H. S. Teachers
  US National Chemistry Olympiad
  Younger Chemists

  Long Island
         Env Chem
         HS Awards
  Staten Island

New York Section
   Annual Reports (PDF)
      2017 Summary (3.1 MB)
          (w/attachments, 175 MB)
      2016 Summary (4.7 MB)
      2015 Summary (6.8 MB)
      2014 Summary (3.3 MB)
      2013 Summary (3.5 MB)
      2012 Summary (31.1 MB)
      2011 Summary (59.5 MB)
      2010 Summary (14.4 MB)
      2009 (HTML)
      2008 (HTML)
      2007 (HTML)
    Event Reporting Form (MS.docx)
    Expense Form (MS.docx)
    Expense Form (PDF)

National ACS
   ACS Network
   Webinars en EspaƱoll

Support Your Local Section